Brief: Zydus Lifesciences Launches Biosimilar Denosumab 120 Mg SC
Dec 10 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES - LAUNCHES BIOSIMILAR DENOSUMAB 120 MG SC ZYDUS LIFESCIENCES - ‘ZYRIFA’ IS PRICED AT MRP OF 12,495 RUPEES Further company coverage: ZYDU.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka